Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Gut microbial markers of immunotherapy response in melanoma: a cross-cohort analysis including the first Russian dataset.

Gut microbes·2026
Same author

Fluorescent Aptamers Go Viral: Tracking the Coseparation of a SARS-CoV-2 RNA Fragment with the Nucleocapsid Protein Using the Encoded Mango II Tag.

ACS synthetic biology·2026
Same author

Duplication of the Antistasin-Like Structure Resulted in a New Anticoagulant Protein in the Medicinal Leech.

Biomolecules·2026
Same author

Beyond Direct Fibrinolysis: Novel Approaches to Thrombolysis.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Production, Purification, and Characterization of a Novel Cysteine-Rich Anticoagulant from the Medicinal Leech and the Functional Role of Its C-Terminal Motif.

Biomolecules·2025
Same author

Development of New Antimicrobial Peptides by Directional Selection.

Antibiotics (Basel, Switzerland)·2025

相关实验视频

Updated: Jan 7, 2026

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

2.2K

重组RGD-Apoptins降低人类黑色素瘤细胞活力

Dmitriy Shirokov1,2, Daria Lepekhina1, Valentin Manuvera1,3

  • 1Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia.

International journal of molecular sciences
|December 30, 2025
PubMed
概括
此摘要是机器生成的。

新型RGD-阿波丁蛋白在治疗黑色素瘤方面表现有前途. 这些工程蛋白专门向癌细胞,诱导细胞亡,同时保护健康组织,为这种危险的皮肤癌提供了潜在的新疗法策略.

关键词:
这就是MeWoWoWo的意思.这是一种RGD.这就是Apoptinoptin.灭症 (apoptosis) 是一种死亡的过程.双重特异性对结合性蛋白质的双重特异性黑色素瘤是一种黑色素瘤.用于治疗的重组蛋白质.转录组学 转录组学是指转录组学.αVβ3 整合素的组成部分

更多相关视频

Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis
07:48

Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis

Published on: January 7, 2019

7.3K
Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

6.0K

相关实验视频

Last Updated: Jan 7, 2026

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

2.2K
Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis
07:48

Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis

Published on: January 7, 2019

7.3K
Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

6.0K

科学领域:

  • 在瘤学瘤学.
  • 分子生物学分子生物学
  • 生物技术是生物技术.

背景情况:

  • 皮肤黑色素瘤是一种危险的皮肤癌,晚期预后不佳.
  • 恶性黑色素瘤占皮肤瘤的一小部分,但死亡率很高.
  • 开发新黑色素瘤治疗策略是一个关键的医疗需求.

研究的目的:

  • 为了生产和评估新型重组蛋白,RGD-apoptins,用于抗黑色素瘤活性.
  • 在人类细胞模型中评估RGD-apoptins的特异性和有效性.
  • 研究由RGD-apoptins诱导的细胞死亡机制.

主要方法:

  • 使用大肠杆菌表达系统生产RGD-apoptins.
  • 在黑色素瘤细胞,角质细胞和纤维细胞中使用resazurin和annexin V测定对RGD-apoptin细胞毒性的评估.
  • 转录组分析用于研究治疗后的基因表达变化.

主要成果:

  • RGD-apoptins显著降低了MeWo人类黑色素瘤细胞的活力.
  • RGD-apoptins没有影响HaCaT人类角质细胞或原发性皮肤纤维细胞的活力,这表明特异性.
  • 黑色素瘤细胞的细胞死亡被证实是通过亡发生的.
  • 转录组分析提供了对基因表达变化的动态见解.

结论:

  • 通过诱导癌细胞的亡,RGD-apoptins表现出特定的抗黑色素瘤活性.
  • RGD和阿波丁成分有助于向输送和瘤细胞死亡.
  • 这些发现支持RGD-apoptins作为皮肤黑色素瘤向治疗的潜力.